ImmunityBio, Inc.的动态

? How are prognostic scores factored into #myelofibrosis frontline therapy planning? ?? In this roundtable moderated by Ruben Mesa, MD, learn the history of prognostic scoring systems from Naveen Pemmaraju, MD and how it's used to make treatment decisions! ?? https://buff.ly/3WMN6JY

Managing anemia in lower-risk myelodysplastic neoplasms (MDS) is vital for patient care. In the latest edition of?Oncolytics Today, Dr. Nikolaos Papadantonakis discusses the effectiveness of erythropoietin-stimulating agents and luspatercept, emphasizing the need for further research to explore treatment synergies and resistance mechanisms in MDS. Read more: ?https://lnkd.in/euuUrFTS? #BloodCancerAwarenessMonth #CancerCare?

Sydney System for Gastric Biopsies: ? Enhanced diagnostic accuracy through a comprehensive biopsy approach ? Better understanding of the extent and severity of gastritis ? Informed treatment planning and improved patient outcomes https://lnkd.in/eqr4dW9M

Paul W. Noble, MD, discusses key unmet needs in idiopathic pulmonary fibrosis therapies in this K-Cast series. They highlight the potential for novel treatments to optimize patient outcomes and discuss how the GAP model can help determine patient prognosis. Watch the program here to learn more: https://bit.ly/3VYeOSZ #ManagedCare

On the eleventh day of OA/US, Imagio? gave to me: more diagnostic workups for necessary patients and increased capacity... #BreastCancer #optoacoustic #ImagioImaging

Are you up to date with this? ?? There are many different treatment approaches for patients with newly diagnosed #MultipleMyeloma. Take a look at this visual abstract on a real-world retrospective study, which highlights the outcomes of patients eligible for transplant. https://loom.ly/iQNDuRQ #mmsm #myeloma

This rare and heterogeneous group affects both bones and soft tissues, making it crucial to raise awareness and support research efforts. Understanding the diversity of sarcoma is key to developing effective treatments and improving patient outcomes. Subscribe to: https://lnkd.in/eEMW_CyS to learn more. #SarcomaAwareness #RareCancers #CancerResearch #SupportCancerResearch #HealthAwareness #FightCancer

How does #fruquintinib compare to other treatments such as #bevacizumab for #colorectalcancer? Cathy Eng, MD, FACP, FASCO, Vanderbilt University, discusses why fruquintinib may be a better treatment for some patients, especially for those with myelosuppression. Watch the full interview on FRESCO-2 with Dr. Cathy Eng here: https://buff.ly/3PjZtIE

This #StandUpToCancer day, learn more about #HepaticArteryInfusion therapy, a powerful option for patients with #ColorectalCancer that has spread to the liver and #Cholangiocarcinoma: https://bit.ly/493PHBU #HAItherapy #HAIpump